ADMA Biologics to Present at the Rodman & Renshaw Annual Global Investment Conference
07:00 EDT 6 Sep 2012 | Businesswire
This article has expired, however you can still
download the PDF.
Preview:
ADMA Biologics, Inc. (ADMA), a late-stage biotechnology company focused
on the development and commercialization of human plasma and
plasma-derived therapeutics, today announced it is scheduled to present
at the Rodman & Ren...
Other Sources for this Article
ADMA Biologics, Inc.
Adam S. Grossman
President & CEO
or
Brian
Lenz, CPA
Vice President & Chief Financial Officer
201-478-5552
info@admabio.com
More From BioPortfolio on "ADMA Biologics to Present at the Rodman & Renshaw Annual Global Investment Conference"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
